HY-13255A-1mL
|
MedChemexpress LLC
|
TAME hydrochloride [CAS 1784-03-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-116572A-10mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
HY-116572A-100mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
HY-116572A-25mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
HY-116572A-5mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
HY-116572A-50mg
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1]
|
|
Cancer-programmed cell death
|
|
HY-116572A-1mL
|
MedChemexpress LLC
|
TASIN-1 [CAS 792927-06-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P72271-10ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
HY-P72271-2ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
HY-P72271-50ug
|
MedChemexpress LLC
|
TRAC, Human (P.pastoris, His)
|
|
|
|
HY-105999B-1mg
|
MedChemexpress LLC
|
APC 366 (TFA) [CAS 2421110-28-1]
|
|
|
|
HY-105999-5mg
|
MedChemexpress LLC
|
APC 366 [CAS 158921-85-8]
|
|
COVID-19-immunoregulation
|
|
HY-110287-1mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-10mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-100mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-25mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-5mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-50mg
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7]
|
|
Cancer-programmed cell death
|
|
HY-110287-1mL
|
MedChemexpress LLC
|
Apcin [CAS 300815-04-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-130841-10mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-100mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-25mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-5mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-50mg
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0]
|
|
Cancer-programmed cell death
|
|
HY-130841-1mL
|
MedChemexpress LLC
|
Apcin-A [CAS 1683617-62-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|